|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500103111 |
|
最近更新日期: Date of Last Refreshed on: |
2025-05-26 08:10:53 |
|
注册时间: Date of Registration: |
2025-05-26 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
胫骨平台混合式固定假体应用于合并骨质疏松症患者的初次人工全膝关节置换术:一项多中心观察性研究 |
|
Public title: |
Tibial plateau hybrid fixation prosthesis for primary total knee arthroplasty in patients with osteoporosis: a multicenter observational study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
胫骨平台混合式固定假体应用于合并骨质疏松症患者的初次人工全膝关节置换术:一项多中心观察性研究 |
|
Scientific title: |
Tibial plateau hybrid fixation prosthesis for primary total knee arthroplasty in patients with osteoporosis: a multicenter observational study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
雷鹏飞 |
研究负责人: |
雷鹏飞 |
|
Applicant: |
Pengfei Lei |
Study leader: |
Pengfei Lei |
|
申请注册联系人电话: Applicant telephone: |
+86 571 8723 3531 |
研究负责人电话:
Study leader's |
+86 571 8723 3531 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
leipengfei@zju.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
leipengfei@zju.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
浙江省杭州市庆春路79号 |
研究负责人通讯地址: |
浙江省杭州市庆春路79号 |
|
Applicant address: |
No. 79 Qingchun road, Hangzhou, Zhejiang province |
Study leader's address: |
No. 79 Qingchun road, Hangzhou, Zhejiang province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
浙江大学附属第一医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital, College of Medicine, Zhejiang University |
||
|
研究负责人所在单位: |
浙江大学附属第一医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital, College of Medicine, Zhejiang University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
[2025B]0251 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
浙江大学医学院附属第一医院IIT伦理审查委员会 |
||
|
Name of the ethic committee: |
Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-03-04 00:00:00 | ||
|
伦理委员会联系人: |
厉有名 |
||
|
Contact Name of the ethic committee: |
Youming Li |
||
|
伦理委员会联系地址: |
浙江省杭州市庆春路79号 |
||
|
Contact Address of the ethic committee: |
No. 79 Qingchun road, Hangzhou, Zhejiang province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 571 8723 3418 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
浙江大学医学院附属第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital, College of Medicine, Zhejiang University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省杭州市庆春路79号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 79 Qingchun road, Hangzhou, Zhejiang province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-financing |
||||||||||||||||||||||
|
研究疾病: |
膝关节骨关节炎 |
||||||||||||||||||||||
|
Target disease: |
Osteoarthritis of knee joint |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
本研究以合并老年骨质疏松的初次全膝关节置换术患者为研究对象,通过TMK混合固定假体和TMK全水泥固定假体的临床回顾性研究,评估两种假体在临床结果和植入后胫骨平台位移方面是否具有差异。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study focuses on elderly patients undergoing primary total knee arthroplasty with osteoporosis. Through a clinical retrospective study of TMK hybrid fixation prostheses and TMK fully cemented fixation prostheses, we evaluated whether there are differences in the clinical outcomes and post-implantation tibial plateau displacement between the two prostheses. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. 年龄大于50周岁 2. 根据体格检查和有临床和放射学证实的膝关节骨性关节炎病史 3. 拟行初次全膝关节置换术 4. 确诊骨质疏松症/骨量减少 |
||||||||||||||||||||||
|
Inclusion criteria |
1. The age is over 50 years old. 2. According to the physical examination and the history of knee osteoarthritis confirmed by clinical and radiology 3. The first total knee arthroplasty is proposed. 4. Diagnosed osteoporosis / osteopenia |
||||||||||||||||||||||
|
排除标准: |
1. 既往有过严重关节外伤导致畸形 2. 肢体偏瘫、下肢肌力差者 3. 不能耐受手术 4. 术前膝关节存在骨缺损 5. 体重指数大于 40 kg/m^2 6. 任意关节或全身有活动性感染或疑似感染 7. 拒绝签署知情同意书,不能完成定期随访 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. There have been deformities caused by severe joint trauma in the past. 2. Hemiplegia of limbs and poor muscle strength of lower extremities. 3. Can't tolerate surgery 4. There is a bone defect in the knee joint before operation. 5. Body mass index (BMI) is higher than 40kg/m^2 6. Any joint or whole body has active infection or suspected infection 7. Refuse to sign informed consent form and fail to complete regular follow-up |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-06-01 00:00:00至 To 2028-05-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-06-01 00:00:00 至 To 2027-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不适用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not applicable |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |